Commentary
Video
Author(s):
D. Ross Camidge, MD, PhD, of University of Colorado Health Lung Cancer Clinic – Anschutz Medical Campus, discusses standard treatments for patients with non–small cell lung cancer who harbor NRG1 fusions.
A Geneticist and PCP Detail Considerations With New Screening Recommendations for Breast Cancer
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Nivolumab Plus Ipilimumab and Chemo Maintains OS Benefit in NSCLC
Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection
Perioperative Nivolumab Regimen Improves EFS, Resection Rates in Stage III N2/non-N2 NSCLC
Dato-DXd Demonstrates Intracranial Activity in Advanced NSCLC With/Without Brain Metastases
Linvoseltamab Generates Efficacy Similar to That Seen With Teclistamab in R/R Myeloma
Dostarlimab With Carboplatin/Paclitaxel Shows Survival Benefits in dMMR/MSI-H Endometrial Cancer
Pembrolizumab With Platinum-Based Therapy is Safe and Efficacious in PSCC
Dr Hughes on Efficacy Data for Asciminib in Newly Diagnosed Ph+ CP-CML